(Press-News.org) Leading diabetes drug lowers blood sugar by interfering with mitochondria
CHICAGO --- Millions of people take metformin, a Type 2 diabetes medication that lowers blood sugar. The “wonder drug” has also been shown to slow cancer growth, improve COVID outcomes and reduce inflammation. But until now, scientists have been unable to determine how, exactly, the drug works.
A new Northwestern Medicine study has provided direct evidence in mice that the drug reversibly cuts the cell’s energy supply by interfering with mitochondria, often referred to as the cell’s “powerhouse,” to lower glucose levels.
More specifically, metformin blocks a specific part of the cell's energy-making machinery called mitochondrial complex I. In doing so, the drug can target cells that may be contributing to disease progression without causing significant harm to normal, healthy cells.
The study will be published Dec. 18 in the journal Science Advances.
“This research gives us a clearer understanding of how metformin works,” said corresponding author Navdeep Chandel, the David W. Cugell, MD, Professor of Medicine (Pulmonology and Critical Care), investigator with the Chan Zuckerberg Initiative and a professor of biochemistry and molecular genetics at Northwestern University Feinberg School of Medicine. The study’s first author is Colleen Reczek, research assistant professor of medicine (pulmonary and critical care medicine) at Feinberg.
“This research significantly advances our understanding of metformin’s mechanism of action,” Chandel said. “While millions of people take metformin, understanding its exact mechanism has been a mystery. This study helps explain that metformin lowers blood sugar by interfering with mitochondria in cells.”
Metformin has been used as a diabetes treatment for more than 60 years. The relatively inexpensive medication, which derives from compounds in the French lilac plant, is the first line of defense for many patients with Type 2 diabetes worldwide, Chandel said. In the U.S., some patients take it alongside other medications like new diabetes and weight-loss drugs — semaglutides such as Ozempic or Mounjaro.
Scientists have many theories about metformin’s effect on cells, but the theories are often grounded in research from distinct fields and have provided only indirect evidence to back hypotheses, Chandel said.
“Every year there's a new mechanism, a new target of metformin, and the next few years people debate those and don't come to a consensus,” Chandel said.
Because metformin requires a transporter to access the interior of cells — where mitochondria live — it affects only a handful of cell types, mostly in the gut, liver and kidney. To test mitochondrial complex I’s role in glucose reduction, Reczek created mice genetically engineered to express a yeast enzyme (NDI1) that mimics mitochondrial complex I but is resistant to metformin inhibition.
They compared blood glucose levels in mice with and without metformin, and with or without the expressed yeast NDI1 protein. Glucose levels in the control mice lowered upon metformin administration. By contrast, NDI1-expressing mice ameliorated metformin reduction in glucose levels, indicating that metformin targets mitochondrial complex I to reduce glucose levels.
“The NDI1-expressing mice were not completely resistant to its glucose-lowering effects, suggesting metformin may also target other pathways to some extent, but more research is needed,” Chandel said.
Previously, the Chandel group had used NDI1 to demonstrate that metformin anti-cancer effects in cells that express the transporter for metformin were also due to inhibition of mitochondrial complex I in cancer cells.
Moreover, one of the co-authors of the current study, Dr. Scott Budinger, chief of pulmonary and critical care in the department of medicine at Feinberg, has previously shown with Chandel that metformin can decrease pollution-induced inflammation in mice by interfering with mitochondrial complex I.
“We think that the diverse effects metformin has on lowering glucose levels, decreasing inflammation and its potential anti-cancer effects could, in part, be explained by inhibiting mitochondrial complex I,” Chandel said. “Eventually, others will have to corroborate our idea of mitochondrial complex I inhibition as a unifying mechanism to explain how metformin could improve healthspan in humans.”
END
Chinese researchers recently revealed new insights on the growth of craniopharyngioma and identified a potential therapeutic treatment.
Their findings were published online in Science Translational Medicine on December 19.
Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its proximity to critical brain structures often leads to severe endocrine and metabolic complications. The tumor can invade the hypothalamus and pituitary gland, resulting in endocrine dysfunction and metabolic disorders ...
Massive volcanic eruptions on the Indian peninsula have long been proposed as an alternative cause for the demise of the dinosaurs. This phase of active volcanism took place in a period just before the Earth was struck by a meteorite, 66 million years ago. The effect of these volcanic eruptions on the Earth’s climate has been topic of fierce scientific debates for decades. Now, climate scientists from Utrecht University and the University of Manchester show that, while the volcanism caused a temporary cold period, the effects had already worn off thousands of years before the meteorite impacted. The scientists therefore conclude that the meteorite impact was the ...
A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.
Scientists from EMBL Heidelberg were part of a collaborative effort to discover an effective treatment for lung fibrosis and found that the best candidate may be one that is already available as a cough medicine around the world, dextromethorphan. The study was recently published in Science Translational Medicine and showed how dextromethorphan can impede ...
Researchers at the University of California San Diego School of Medicine have shown that a systemic approach to eliminating inefficiencies in surgical residency programs can reduce unnecessary work hours in the general residency program at UC San Diego. The approach—based on Lean methodology—can also positively impact the training and overall well-being of surgery residents. The results are published today in the Journal of the American Medical Association (JAMA).
“Our study shows ...
Research from Radboud university medical center shows that the lockdowns during the COVID-19 pandemic had a significant impact on people's immune response to microorganisms. During the lockdown, inflammation level in the body was low, but afterwards, the immune system reacted more intensely to viruses and bacteria. The results are now published in Frontiers of Immunology.
In this study, the researchers examined the effects of various health measures introduced during the pandemic, such as lockdowns and vaccinations. The study was conducted in a large cohort of people living with HIV, as well as in healthy individuals. The researchers ...
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Smoking cessation medications are safe and effective for people with depression
Individuals with major depressive disorder (MDD) are more likely to smoke, leading to higher risks of nicotine addiction and early death from tobacco-related illnesses. To identify the best treatments for quitting, researchers led by George ...
Scientists have spotted a massive black hole in the early universe that is ‘napping’ after stuffing itself with too much food.
Like a bear gorging itself on salmon before hibernating for the winter, or a much-needed nap after Christmas dinner, this black hole has overeaten to the point that it is lying dormant in its host galaxy.
An international team of astronomers, led by the University of Cambridge, used the NASA/ESA/CSA James Webb Space Telescope to detect this black hole in the early universe, just 800 million years after the Big Bang.
The black hole is huge – ...
Much like plants in a thriving forest, certain cells in the brain create a nurturing environment, enhancing the health and resilience of their neighbors, while others promote stress and damage, akin to a noxious weed in an ecosystem.
A new study published in Nature on December 18, 2024, reveals these interactions playing out across the lifespan. It suggests local cellular interactions may profoundly influence brain aging — and offers fresh insights into how we might slow or even reverse the process.
“What was exciting to us was finding that some cells have a pro-aging effect on neighboring cells while others appear to have a rejuvenating effect on their neighbors,” ...
The electronics industry is approaching a limit to the number of transistors that can be packed onto the surface of a computer chip. So, chip manufacturers are looking to build up rather than out.
Instead of squeezing ever-smaller transistors onto a single surface, the industry is aiming to stack multiple surfaces of transistors and semiconducting elements — akin to turning a ranch house into a high-rise. Such multilayered chips could handle exponentially more data and carry out many more complex functions than today’s electronics.
A significant hurdle, however, is the platform on which chips are built. Today, bulky ...
MIT physicists have created a new and long-lasting magnetic state in a material, using only light.
In a study that will appear in Nature, the researchers report using a terahertz laser — a light source that oscillates more than a trillion times per second — to directly stimulate atoms in an antiferromagnetic material. The laser’s oscillations are tuned to the natural vibrations among the material’s atoms, in a way that shifts the balance of atomic spins toward a new magnetic state.
The results provide a new way to control and switch antiferromagnetic materials, which are of interest for their potential ...
